Induction of NKG2D Ligands and Increased Sensitivity of Tumor Cells to NK Cell-mediated Cytotoxicity by Hematoporphyrin-based Photodynamic Therapy

REFERENCES

• Armeanu, S., Bitzer, M., Lauer, U. M., Venturelli, S., Pathil, A., Krusch, M., Kaiser, S., Jobst, J., Smirnow, I., Wagner, A., and others (2005). Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Res. 65:6321–6329.
   PubMed Web of Science ®Google Scholar
• Bae, J. H., Kim, J. Y., Kim, M. J., Chang, S. H., Park, Y. S., Son, C. H., Park, S. J., Chung, J. S., Lee, E. Y., Kim, S. H., and others (2010). Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70. J. Immunother. 33:391–401.
   Google Scholar
• Barr, H., Tralau, C. J., Boulos, P. B., MacRobert, A. J., Tilly, R., Bown, S. G. (1987). The contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal injury. Photochem. Photobiol. 46:795–800.
   PubMedGoogle Scholar
• Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., Spies, T (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727–729.
   PubMed Web of Science ®Google Scholar
• Biassoni, R., Cantoni, C., Marras, D., Giron-Michel, J., Falco, M., Moretta, L., Dimasi, N. (2003). Human natural killer cell receptors: Insights into their molecular function and structure. J. Cell. Mol. Med. 7:376–387.
   PubMed Web of Science ®Google Scholar
• Biron, C. A. (1997) Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9:24–34.
   PubMed Web of Science ®Google Scholar
• Borchers, M. T., Harris, N. L., Wesselkamper, S. C., Vitucci, M., Cosman, D. (2006). NKG2D ligands are expressed on stressed human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 291:L222–L231.
   PubMed Web of Science ®Google Scholar
• Buytaert, E., Dewaele, M., Agostinis, P. (2007). Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim. Biophys, Acta 1776:86–107.
   PubMed Web of Science ®Google Scholar
• Castano, A. P., Mroz, P., Hamblin, M. R. (2006). Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer 6:535–545.
   PubMed Web of Science ®Google Scholar
• Cecic, I., Korbelik, M. (2002). Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett. 183:43–51.
   PubMed Web of Science ®Google Scholar
• Cecic, I., Parkins, C. S., Korbelik, M. (2001). Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors. Photochem. Photobiol. 74:712–720.
   PubMed Web of Science ®Google Scholar
• Cecic, I., Stott, B., Korbelik, M. (2006). Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy. Int. Immunopharmacol. 6:1259–1266.
   PubMed Web of Science ®Google Scholar
• Cerwenka, A., Bakker, A. B., McClanahan, T., Wagner, J., Wu, J., Phillips, J. H., Lanier, L. L. (2000). Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12:721–727.
   PubMed Web of Science ®Google Scholar
• Cooper, M. A., Fehniger, T. A., Caligiuri, M. A. (2001). The biology of human natural killer-cell subsets. Trends Immunol. 22:633–640.
   PubMed Web of Science ®Google Scholar
• de Vree, W. J., Essers, M. C., Koster, J. F., Sluiter, W. (1997). Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. Cancer Res. 57:2555–2558.
   PubMedGoogle Scholar
• Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., Raulet, D. H. (2000). Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:119–126.
   PubMed Web of Science ®Google Scholar
• Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., Peng, Q. (1998). Photodynamic therapy. J. Natl. Cancer Inst. 90:889–905.
   PubMed Web of Science ®Google Scholar
• Eagle, R. A., Traherne, J. A., Ashiru, O., Wills, M. R., Trowsdale, J. (2006). Regulation of NKG2D ligand gene expression. Hum. Immunol. 67:159–169.
   PubMed Web of Science ®Google Scholar
• Gasser, S., Orsulic, S., Brown, E. J., Raulet, D. H. (2005). The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436:1186–1190.
   PubMed Web of Science ®Google Scholar
• Gollnick, S. O., Evans, S. S., Baumann, H., Owczarczak, B., Maier, P., Vaughan, L., Wang, W. C., Unger, E., Henderson, B. W. (2003). Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br. J. Cancer 88:1772–1779.
   PubMed Web of Science ®Google Scholar
• Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., Spies, T. (2001). Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2:255–260.
   PubMed Web of Science ®Google Scholar
• Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., Spies, T. (1999). Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA 96:6879–6884.
   PubMed Web of Science ®Google Scholar
• Kabingu, E., Vaughan, L., Owczarczak, B., Ramsey, K. D., Gollnick, S. O. (2007). CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells. Br. J. Cancer 96:1839–1848.
   PubMed Web of Science ®Google Scholar
• Kato, N., Tanaka, J., Sugita, J., Toubai, T., Miura, Y., Ibata, M., Syono, Y., Ota, S., Kondo, T., Asaka, M., and others (2007) Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells. Leukemia 21:2103–2108.
   PubMed Web of Science ®Google Scholar
• Kim, J. Y., Bae, J. H., Lee, S. H., Lee, E. Y., Chung, B. S., Kim, S. H., Kang, C. D. (2008). Induction of NKG2D ligands and subsequent enhancement of NK Cell-mediated lysis of cancer cells by arsenic trioxide. J. Immunother. 31:475–486.
   PubMedGoogle Scholar
• Kim, J. Y., Son, Y. O., Park, S. W., Bae, J. H., Chung, J. S., Kim, H. H., Chung, B. S., Kim, S. H., Kang, C. D. (2006). Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation. Exp. Mol. Med. 38:474–484.
   PubMed Web of Science ®Google Scholar
• Korbelik, M., Sun, J. (2001). Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line. Int. J. Cancer 93:269–274.
   PubMedGoogle Scholar
• Kubba, A. K. (1999). Role of photodynamic therapy in the management of gastrointestinal cancer. Digestion 60:1–10.
   PubMedGoogle Scholar
• Lanier, L. L. (2001). On guard—activating NK cell receptors. Nat. Immunol. 2:23–27.
   PubMed Web of Science ®Google Scholar
• Lee, S. J., Son, Y. O., Kim, H., Kim, J. Y., Park, S. W., Bae, J. H., Kim, H. H., Lee, E. Y., Chung, B. S., Kim, S. H., and others (2007). Suppressive effect of a standardized mistletoe extract on the expression of activatory NK receptors and function of human NK cells. J. Clin. Immunol. 27:477–485.
   PubMed Web of Science ®Google Scholar
• Ljunggren, H. G., Karre, K. (1990). In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol. Today 11:237–244.
   PubMedGoogle Scholar
• Ljunggren, H. G., Malmberg, K. J. (2007). Prospects for the use of NK cells in immunotherapy of human cancer. Nat. Rev. Immunol. 7:329–339.
   PubMed Web of Science ®Google Scholar
• Maki, G., Klingemann, H. G., Martinson, J. A., Tam, Y. K. (2001). Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92. J. Hematother. Stem Cell Res. 10:369–383.
   PubMedGoogle Scholar
• McBride, G. (2002). Studies expand potential uses of photodynamic therapy. J. Natl. Cancer Instit. 94:1740–1742.
   PubMed Web of Science ®Google Scholar
• McCaughan, J. S., Jr., Guy, J. T., Hawley, P., Hicks, W., Inglis, W., Laufman, L., May, E,. Nims, T. A., Sherman, R. (1983). Hematoporphyrin-derivative and photoradiation therapy of malignant tumors. Lasers Surg. Med. 3:199–209.
   PubMedGoogle Scholar
• McCaughan, J. S., Jr., Hicks, W., Laufman, L., May, E., Roach, R. (1984). Palliation of esophageal malignancy with photoradiation therapy. Cancer 54:2905–2910.
   PubMed Web of Science ®Google Scholar
• Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., Moretta, L. (2001). Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197–223.
   PubMed Web of Science ®Google Scholar
• Nseyo, U. O., Whalen, R. K., Duncan, M. R., Berman, B., Lundahl, S. L. (1990). Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report. Urology 36:167–171.
   PubMed Web of Science ®Google Scholar
• Ortel, B., Shea, C. R., Calzavara-Pinton, P. (2009). Molecular mechanisms of photodynamic therapy. Front. Biosci. 14:4157–4172.
   Web of Science ®Google Scholar
• Park, S. W., Bae, J. H., Kim, S. D., Son, Y. O., Kim, J. Y., Park, H. J., Lee, C. H., Park, D. Y., Lee, M. K., Chung, B. S., and others (2007). Comparison of level of NKG2D ligands between normal and tumor tissue using multiplex RT-PCR. Cancer Invest. 25:299–307.
   PubMed Web of Science ®Google Scholar
• Poggi, A., Venturino, C., Catellani, S., Clavio, M., Miglino, M., Gobbi, M., Steinle, A., Ghia, P, Stella S, Caligaris-Cappio F and others (2004) Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid. Cancer Res. 64:9172–9179.
   PubMed Web of Science ®Google Scholar
• Rohner, A., Langenkamp, U., Siegler, U., Kalberer, C. P., Wodnar-Filipowicz, A. (2007) .Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis. Leuk. Res. 31:1393–1402.
   PubMed Web of Science ®Google Scholar
• Sharman, W. M., Allen, C. M., van Lier, J. E. (2000). Role of activated oxygen species in photodynamic therapy. Meth. Enzymol. 319:376–400.
   PubMed Web of Science ®Google Scholar
• Skov, S., Pedersen, M. T., Andresen, L., Straten, P. T., Woetmann, A., Odum, N. (2005). Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. Cancer Res. 65:11136–11145.
   PubMed Web of Science ®Google Scholar
• Tam, Y. K., Martinson, J. A., Doligosa, K., Klingemann, H. G. (2003). Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy. Cytotherapy 5:259–272.
   PubMed Web of Science ®Google Scholar
• Trinchieri, G. (1989). Biology of natural killer cells. Adv. Immunol. 47:187–376.
   PubMed Web of Science ®Google Scholar
• van Duijnhoven, F. H., Aalbers, R. I., Rovers, J. P., Terpstra, O. T., Kuppen, P. J. (2003). Immunological aspects of photodynamic therapy of liver tumors in a rat model for colorectal cancer. Photochem. Photobiol. 78:235–240.
   PubMedGoogle Scholar
• Vivier, E., Tomasello, E., Paul, P. (2002). Lymphocyte activation via NKG2D: Towards a new paradigm in immune recognition? Curr. Opin. Immunol. 14:306–311.
   PubMed Web of Science ®Google Scholar
• Yom, S. S., Busch, T. M., Friedberg, J. S., Wileyto, E. P., Smith, D., Glatstein, E., Hahn, S. M. (2003). Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy. Photochem. Photobiol. 78:75–81.
   PubMedGoogle Scholar
• Zhang, C., Wang, Y., Zhou, Z., Zhang, J., Tian, Z. (2009). Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis. Cancer Immunol. Immunother. 58:1275–1285.
   Google Scholar
• Ziolkowski, P., Symonowicz, K., Milach, J., Zawirska, B., Szkudlarek, T. (1997). In vivo tumor necrosis factor-alpha induction following chlorin e6-photodynamic therapy in Buffalo rats. Neoplasma 44:192–196.
   PubMedGoogle Scholar